FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Glenmark Therapeutics Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for citalopram hydrobromide from Glenmark Therapeutics USA, indicating an approved update to its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Citalopram Hydrobromide (citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)